Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBDEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
EB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.10.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.10.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KC.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KC.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KL.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
KL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HC.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HC.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.37EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.37EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.61EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.61EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.153EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.153EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.33EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JB.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
JB.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
A.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
A.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XDK.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.58EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.58EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.1.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.4.1.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.6EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.3.6EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.459EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.459EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.117EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.117EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.381EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.381EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.237EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.237EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.382EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.382EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.395EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.395EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.323EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used